vs
Avalon GloboCare Corp.（ALBT）与CI&T Inc（CINT）财务数据对比。点击上方公司名可切换其他公司
CI&T Inc的季度营收约是Avalon GloboCare Corp.的1398.6倍（$489.6M vs $350.1K）。CI&T Inc净利率更高（8.3% vs -72.6%，领先80.9%）。CI&T Inc同比增速更快（11.5% vs 1.4%）
Avalon GloboCare Corp.是一家全球化生物技术与医疗服务提供商，专注于细胞与基因疗法研发、再生医学解决方案落地及转化医学研究创新，业务覆盖北美及亚洲核心市场，为医疗相关主体提供定制化专业服务。
CI&T Inc是全球数字化转型服务提供商，提供定制软件开发、云迁移、数据分析、用户体验设计、人工智能落地等端到端解决方案，服务零售、金融、医疗、制造等多个行业客户，业务覆盖美洲、欧洲及亚太地区。
ALBT vs CINT — 直观对比
营收规模更大
CINT
是对方的1398.6倍
$350.1K
营收增速更快
CINT
高出10.1%
1.4%
净利率更高
CINT
高出80.9%
-72.6%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $350.1K | $489.6M |
| 净利润 | $-254.3K | $40.6M |
| 毛利率 | — | 32.0% |
| 营业利润率 | -21.8% | 13.4% |
| 净利率 | -72.6% | 8.3% |
| 营收同比 | 1.4% | 11.5% |
| 净利润同比 | 84.9% | 37.7% |
| 每股收益（稀释后） | $-0.06 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALBTCINT
| Q4 25 | — | $489.6M | ||
| Q3 25 | $350.1K | — | ||
| Q2 25 | $350.4K | — | ||
| Q1 25 | $349.8K | — | ||
| Q4 24 | $345.8K | $439.0M | ||
| Q3 24 | $345.2K | — | ||
| Q2 24 | $327.9K | — | ||
| Q1 24 | $314.6K | — |
净利润ALBTCINT
| Q4 25 | — | $40.6M | ||
| Q3 25 | $-254.3K | — | ||
| Q2 25 | $-13.5M | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | — | $29.5M | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | $-2.1M | — | ||
| Q1 24 | $-1.4M | — |
毛利率ALBTCINT
| Q4 25 | — | 32.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 34.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ALBTCINT
| Q4 25 | — | 13.4% | ||
| Q3 25 | -21.8% | — | ||
| Q2 25 | -1109.6% | — | ||
| Q1 25 | -516.5% | — | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | -367.9% | — | ||
| Q2 24 | -458.8% | — | ||
| Q1 24 | -268.0% | — |
净利率ALBTCINT
| Q4 25 | — | 8.3% | ||
| Q3 25 | -72.6% | — | ||
| Q2 25 | -3840.9% | — | ||
| Q1 25 | -709.6% | — | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | -486.5% | — | ||
| Q2 24 | -650.2% | — | ||
| Q1 24 | -434.7% | — |
每股收益（稀释后）ALBTCINT
| Q4 25 | — | $0.30 | ||
| Q3 25 | $-0.06 | — | ||
| Q2 25 | $-6.22 | — | ||
| Q1 25 | $-1.43 | — | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-1.82 | — | ||
| Q2 24 | $-2.85 | — | ||
| Q1 24 | $-1.86 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.9K | $47.9M |
| 总债务越低越好 | — | $122.6M |
| 股东权益账面价值 | $-4.5M | $308.9M |
| 总资产 | $9.1M | $550.5M |
| 负债/权益比越低杠杆越低 | — | 0.40× |
8季度趋势，按日历期对齐
现金及短期投资ALBTCINT
| Q4 25 | — | $47.9M | ||
| Q3 25 | $333.9K | — | ||
| Q2 25 | $201.5K | — | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | — | $56.6M | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $200.6K | — | ||
| Q1 24 | $305.5K | — |
总债务ALBTCINT
| Q4 25 | — | $122.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $138.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALBTCINT
| Q4 25 | — | $308.9M | ||
| Q3 25 | $-4.5M | — | ||
| Q2 25 | $-7.1M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | — | $280.1M | ||
| Q3 24 | $5.4M | — | ||
| Q2 24 | $4.4M | — | ||
| Q1 24 | $6.1M | — |
总资产ALBTCINT
| Q4 25 | — | $550.5M | ||
| Q3 25 | $9.1M | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | — | $526.4M | ||
| Q3 24 | $19.6M | — | ||
| Q2 24 | $19.5M | — | ||
| Q1 24 | $20.3M | — |
负债/权益比ALBTCINT
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $45.8M |
| 自由现金流率自由现金流/营收 | — | 9.4% |
| 资本支出强度资本支出/营收 | — | 3.0% |
| 现金转化率经营现金流/净利润 | — | 1.49× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALBTCINT
| Q4 25 | — | $60.6M | ||
| Q3 25 | $-1.4M | — | ||
| Q2 25 | $-1.2M | — | ||
| Q1 25 | $-1.8M | — | ||
| Q4 24 | $-1.1M | $69.0M | ||
| Q3 24 | $-1.9M | — | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | $-915.7K | — |
自由现金流ALBTCINT
| Q4 25 | — | $45.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $58.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ALBTCINT
| Q4 25 | — | 9.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ALBTCINT
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ALBTCINT
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.34× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
